SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-055083
Filing Date
2023-11-13
Accepted
2023-11-13 19:11:13
Documents
1
Period of Report
2023-11-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8915
  Complete submission text file 0001209191-23-055083.txt   11607
Mailing Address 1134 KLINE STREET LA JOLLA CA 92037
Business Address 1134 KLINE STREET LA JOLLA CA 92037 8583482180
Avalon Ventures XI, L.P. (Reporting) CIK: 0001652901 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40475 | Film No.: 231400939

Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037 858-750-4700
Avalon BioVentures SPV I, L.P. (Reporting) CIK: 0001844550 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40475 | Film No.: 231400938

Mailing Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037 858-750-4700
Avalon BioVentures I, LP (Reporting) CIK: 0001873935 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40475 | Film No.: 231400937